Intranasal Topical Application of Tranexamic Acid in Atraumatic Anterior Epistaxis: A Double-Blind Randomized Clinical Trial

被引:8
|
作者
Hosseinialhashemi, Milad [1 ,2 ]
Jahangiri, Reza [1 ]
Faramarzi, Ali [1 ,2 ]
Asmarian, Naeimehossadat [3 ]
Sajedianfard, Sarvin [1 ,2 ]
Kherad, Maryam [1 ,2 ]
Soltaniesmaeili, Amir [1 ,2 ]
Babaei, Amirhossein [1 ,2 ]
机构
[1] Shiraz Univ Med Sci, Otolaryngol Res Ctr, Dept Otolaryngol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran
[3] Shiraz Univ Med Sci, Anesthesiol & Crit Care Res Ctr, Shiraz, Iran
关键词
MANAGEMENT; UPDATE;
D O I
10.1016/j.annemergmed.2022.04.010
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: To determine the effectiveness of intranasal topical application of tranexamic acid in reducing the need for anterior nasal packing and determine the number of episodes of rebleeding in adult patients presenting with spontaneous atraumatic anterior epistaxis. Methods: This study was a double-blind randomized trial conducted from September to November 2021 in the ears, nose, and throat (ENT) emergency department (ED), Khalili Hospital, Shiraz, Iran. Cotton pledgets soaked in either phenylephrine and lidocaine (control group) or tranexamic acid with phenylephrine and lidocaine (intervention group) were inserted into the patients' nostrils for 15 minutes. The primary outcome was the need for anterior nasal packing. The secondary outcomes were staying in the ED for more than 2 hours, needing electrical cauterization, and rebleeding within 24 hours and 1 to 7 days of the first referral to the ED. The trial was registered with the Iranian Registry of Clinical Trials (IRCT20210403050815N1). Results: A total of 240 patients (120 in each group) were enrolled in this study. Tranexamic acid was associated with a lower rate of need for anterior nasal packing (50.0% versus 64.2%; odds ratio [OR], 0.56; 95% confidence interval [CI], 0.33 to 0.94). There were no significant differences between the 2 groups in terms of the need for electrical cauterization and the rate of rebleeding within 1 to 7 days. Tranexamic acid was associated with a lower rate of stay in the ED for more than 2 hours (9.2% versus 20.8%; OR, 0.38; 95% CI, 0.18 to 0.82) and rebleeding in 24 hours (15.0% versus 30%; OR, 0.41; 95% CI, 0.22 to 0.78) compared with the rates in the control group. Conclusion: Intranasal topical application of tranexamic acid is associated with a lower rate of need for anterior nasal packing and a shortened stay in the ED; it may be considered a part of the treatment for atraumatic anterior epistaxis.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 50 条
  • [1] Appropriate dose of tranexamic acid in the topical treatment of anterior epistaxis, 500 mg vs 1000 mg: A double-blind randomized controlled trial
    Arikan, Cuneyt
    Akyol, Pinar Yesim
    SCIENCE PROGRESS, 2024, 107 (04)
  • [2] Topical Tranexamic Acid in Breast Reconstruction: A Double-Blind Randomized Controlled Trial
    Safran, Tyler
    Vorstenbosch, Joshua
    Viezel-Mathieu, Alex
    Davison, Peter
    Dionisopoulos, Tassos
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2023, 152 (04) : 699 - 706
  • [3] Topical Tranexamic Acid in Breast Reconstruction: A Double-Blind Randomized Controlled Trial
    Brown, Stav
    Rohrich, Rod J.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 154 (02) : 407e - 408e
  • [4] Tranexamic acid in adenotonsillectomy in children: A double-blind randomized clinical trial
    Brum, Marilia Ribeiro
    Miura, Mauricio Schreiner
    de Castro, Samantha Fernandez
    Machado, Graziella Moraes
    Lima, Lucelia Hernandes
    Lubianca Neto, Jose Faibes
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2012, 76 (10) : 1401 - 1405
  • [5] Topical Application of Tranexamic Acid in Primary Total Hip Arthroplasty: A Randomized Double-Blind Controlled Trial
    Yue, Chen
    Kang, Pengde
    Yang, Peiqing
    Xie, Jinwei
    Pei, Fuxing
    JOURNAL OF ARTHROPLASTY, 2014, 29 (12): : 2452 - 2456
  • [6] Topical 5% tranexamic acid for the treatment of melasma in Asians: A double-blind randomized controlled clinical trial
    Ayuthaya, Pinyapat Kanechorn Na
    Niumphradit, Nucha
    Manosroi, Aranya
    Nakakes, Artit
    JOURNAL OF COSMETIC AND LASER THERAPY, 2012, 14 (03) : 150 - 154
  • [7] TOPICAL INTRANASAL TRANEXAMIC ACID FOR SPONTANEOUS EPISTAXIS
    Hilton, Lee
    Reuben, A.
    EMERGENCY MEDICINE JOURNAL, 2014, 31 (05) : 436 - 437
  • [8] Intranasal application of tranexamic acid in patients admitted to emergency facilities for spontaneous anterior epistaxis: a randomized controlled trial
    Dubucs, X.
    ANNALES FRANCAISES DE MEDECINE D URGENCE, 2022, 12 (05): : 340 - 340
  • [9] Use of Tranexamic Acid in Liposculpture: A Double-Blind, Multicenter, Randomized Clinical Trial
    Hoyos, Alfredo E.
    Duran, Hector
    Cardenas-Camarena, Lazaro
    Bayter, Jorge E.
    Cala, Laura
    Perez, Mauricio
    Lopez, Alejandro
    Talleri, Giancarlo
    Dominguez-Millan, Rodrigo
    Mogollon, Ivan R.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 150 (03) : 569 - 577
  • [10] ORAL TRANEXAMIC ACID IN THE MANAGEMENT OF EPISTAXIS - A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL
    WHITE, A
    CLINICAL OTOLARYNGOLOGY, 1988, 13 (04): : 310 - 310